Science & Enterprise subscription

Follow us on Twitter

  • A biotechnology company is developing treatments for cancer and other diseases using Crispr gene editing delivered… https://t.co/cZ13M2gPJk
    about 18 hours ago
  • New post on Science and Enterprise: Biotech Creating More Efficient Crispr Therapies https://t.co/JAfb7hBMoH #Science #Business
    about 18 hours ago
  • I have a Mode joke. It was a Moderna joke, but a messenger lost the RNA.
    about 2 days ago
  • Behind the scenes, CEPI and BARDA were funding vaccine development and covering manufacturing costs. They helped ge… https://t.co/4F5vMbVsrK
    about 3 days ago
  • A YouGov survey taken earlier this month indicates the U.S. public largely supports rejoining the Paris climate agr… https://t.co/eJd2v8G7K8
    about 3 days ago

Please share Science & Enterprise

Biotech Partners for A.I. Drug Discovery in $1B Deal

Artificial intelligence graphic

Two companies are collaborating on the use of artificial intelligence to find new drugs addressing a set of proteins that regulate immune-related functions, including inflammation. . . . → Read More: Biotech Partners for A.I. Drug Discovery in $1B Deal

High Innovation in Rural Regions, Not Just Cities

Farm near mountains

An analysis of supply-chain interactions by businesses in the U.S. shows many more areas of the country create better products and processes than previously believed. . . . → Read More: High Innovation in Rural Regions, Not Just Cities

Strep A Vaccine Project Launched

Streptococcus pyogenes bacteria

An international initiative is underway to begin work on a vaccine against group A streptococcus infections becoming resistant to today’s antibiotics. . . . → Read More: Strep A Vaccine Project Launched

Wireless Sensors Monitor Newborns in ICUs

Amy Paller and Taschana Taylor

An international team developed two wireless sensors that safely monitor the vital signs of newborn infants in intensive care units, replacing the multiple wired devices used today. . . . → Read More: Wireless Sensors Monitor Newborns in ICUs

Lilly Acquiring Treatment for Autoimmune Disorders

(NIH)

19 March 2015. The pharmaceutical company Eli Lilly and Company is acquiring from Hanmi Pharmaceutical, an experimental drug that blocks the actions of an enzyme associated with rheumatoid arthritis and other autoimmune diseases. The deal can pay Hanmi, in Seoul, Korea, as much as $690 million.

Autoimmune disorders are diseases where the . . . → Read More: Lilly Acquiring Treatment for Autoimmune Disorders

Laser Activation Tested as Potential Cancer Drug Delivery

Paras Prasad (University at Buffalo)

16 May 2014. Researchers from University at Buffalo in New York developed and tested in the lab a process harnessing lasers to activate drugs inside the body to kill cancer cells. Findings from the proof-of-concept study, led by Buffalo’s Paras Prasad with colleagues from universities in China and . . . → Read More: Laser Activation Tested as Potential Cancer Drug Delivery

Simple, Sensitive Biosensors Derived from Engineered Viruses

Seung-Wuk Lee (Univ of California, Berkeley)

Bioengineers at University of California in Berkeley developed a process for making sensors from genetically-engineered viruses simple enough to package in a smartphone app, yet can discriminate among volatile chemical vapors. The team from the lab of bioengineering professor Seung-Wuk Lee, with colleagues from Lawrence Berkeley National Lab . . . → Read More: Simple, Sensitive Biosensors Derived from Engineered Viruses

Gold Nanoparticles Configured into Stretchable Conductors

Sample of stretchable conductive material (Joseph Xu, University of Michigan)

Engineers and physicists at University of Michigan in Ann Arbor devised a method for transforming gold nanoparticles into conductive chains that stretch to nearly six times their original length and still conduct a current. The team led by Michigan chemical engineering professor Nicholas . . . → Read More: Gold Nanoparticles Configured into Stretchable Conductors

Merck, Samsung to Collaborate on Biosimilars

(U.S. Army Corps of Engineers)

The pharmaceutical company Merck & Co. in New Jersey and Samsung Bioepis Co. in Seoul, South Korea agreed on a deal for licensing and taking to market non-branded biologic therapies called biosimilars. While the companies released an outline of the financial arrangements, the dollar amount of the agreement . . . → Read More: Merck, Samsung to Collaborate on Biosimilars

Antibiotic Found Effective On Drug-Resistant Tuberculosis

Mycobacterium tuberculosis bacteria (CDC)

Researchers in the U.S. and Korea found the antibiotic linezolid largely effective in treating patients with extensively drug-resistant tuberculosis, who had not responded to previous treatments. The findings of the team led by Clifton Barry of the National Institute of Allergy and Infectious Diseases, part of the National Institutes . . . → Read More: Antibiotic Found Effective On Drug-Resistant Tuberculosis